Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2013 1
2019 1
2021 1
2022 5
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
[Magnetotherapy in patients with malignant tumors receiving immunotherapy].
Koneva ES, Mochalova AS, Suetina MS, Sidyakina IV, Shapovalenko TV, Vasilyeva ES, Butenko AV, Shatveryan GA, Batukhtina EV, Kotenko KV. Koneva ES, et al. Among authors: mochalova as. Vopr Kurortol Fizioter Lech Fiz Kult. 2022;99(4. Vyp. 2):51-60. doi: 10.17116/kurort20229904251. Vopr Kurortol Fizioter Lech Fiz Kult. 2022. PMID: 36083818 Russian.
Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1.
Gershtein ES, Mochalova AS, Korotkova EA, Samoilova EV, Vashketova OI, Kuz'min YB, Sokolov NY, Kushlinskii NE. Gershtein ES, et al. Among authors: mochalova as. Bull Exp Biol Med. 2023 Aug;175(4):481-486. doi: 10.1007/s10517-023-05891-2. Epub 2023 Sep 29. Bull Exp Biol Med. 2023. PMID: 37773572
Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumor.
Gershtein ES, Korotkova EA, Vorotnikov IK, Sokolov NY, Ermilova VD, Mochalova AS, Kushlinskii NE. Gershtein ES, et al. Among authors: mochalova as. Klin Lab Diagn. 2022 Feb 23;67(2):76-80. doi: 10.51620/0869-2084-2022-67-2-76-80. Klin Lab Diagn. 2022. PMID: 35192751 English.
Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy.
Kaidarova DR, Kopp MV, Pokrovsky VS, Dzhugashvili M, Akimzhanova ZM, Abdrakhmanov RZ, Babich EN, Bilan EV, Byakhov AV, Gurov SN, Koroleva IA, Mochalova AS, Povaga SS, Raigorodsky MV, Saifullin AS, Sanz E, Petrovskiy FI. Kaidarova DR, et al. Among authors: mochalova as. Oncol Lett. 2019 Nov;18(5):5644-5652. doi: 10.3892/ol.2019.10868. Epub 2019 Sep 13. Oncol Lett. 2019. PMID: 31641390 Free PMC article.
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
Caricchio R, Abbate A, Gordeev I, Meng J, Hsue PY, Neogi T, Arduino R, Fomina D, Bogdanov R, Stepanenko T, Ruiz-Seco P, Gónzalez-García A, Chen Y, Li Y, Whelan S, Noviello S; CAN-COVID Investigators. Caricchio R, et al. JAMA. 2021 Jul 20;326(3):230-239. doi: 10.1001/jama.2021.9508. JAMA. 2021. PMID: 34283183 Free PMC article. Clinical Trial.
12 results